Related references
Note: Only part of the references are listed.Connexin 43 mimetic peptides inhibit spontaneous epileptiform activity in organotypic hippocampal slice cultures
Marina Samoilova et al.
EXPERIMENTAL NEUROLOGY (2008)
trans-Arachidonic acids induce a heme oxygenase-dependent vasorelaxation of cerebral microvasculature
Amna Kooli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Development of a novel noncompetitive antagonist of IL-1 receptor
Christiane Quiniou et al.
JOURNAL OF IMMUNOLOGY (2008)
Vasopressin receptor mutations in nephrogenic diabetes insipidus
Daniel G. Bichet
SEMINARS IN NEPHROLOGY (2008)
High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor
Vadim Cherezov et al.
SCIENCE (2007)
Critical role for the second extracellular loop in the binding of both orthosteric and allosteric g protein-coupled receptor Ligands
Vimesh A. Avlani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology
Katie Leach et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors
Terry Kenakin
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
The evasive nature of drug efficacy:: implications for drug discovery
Segolene Galandrin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Vasopressin: Mechanisms of action on the vasculature in health and in septic shock
Lucinda K. Barrett et al.
CRITICAL CARE MEDICINE (2007)
Therapeutic potential of vasopressin receptor antagonists
Farhan Ali et al.
DRUGS (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis
Gary L. Robertson
AMERICAN JOURNAL OF MEDICINE (2006)
Tolvaptan: a selective vasopressin type 2 receptor antagonist in congestive heart failure
Umamahesh C. Rangasetty et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Genetic analysis of the first and third extracellular loops of the C5a receptor reveals an essential WXFG motif in the first loop
JM Klco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor
R Macion-Dazard et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
New concepts in drug discovery: Collateral efficacy and permissive antagonism
T Kenakin
NATURE REVIEWS DRUG DISCOVERY (2005)
Analysis of allosterism in functional assays
FJ Ehlert
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based β-arrestin2 recruitment assay
FF Hamdan et al.
JOURNAL OF BIOMOLECULAR SCREENING (2005)
Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-Specific antibodies with human immunodeficiency virus-neutralizing activity
S Khurana et al.
JOURNAL OF VIROLOGY (2005)
Nephrogenic syndrome of inappropriate antidiuresis
BJ Feldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Essential role for the second extracellular loop in C5a receptor activation
JM Klco et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Science Review: Vasopressin and the cardiovascular system - part 2 - clinical physiology
CL Holmes et al.
CRITICAL CARE (2004)
A cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G protein
S Granier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of vasopressin in the management of septic shock
GM Mutlu et al.
INTENSIVE CARE MEDICINE (2004)
Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function
K Kristiansen
PHARMACOLOGY & THERAPEUTICS (2004)
Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances β-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation
PG Charest et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Stereoselective interactions of peptide inhibitors with the β-amyloid peptide
RJ Chalifour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis
S Terrillon et al.
MOLECULAR ENDOCRINOLOGY (2003)
THG113: A novel selective FP antagonist that delays preterm labor
KG Peri et al.
SEMINARS IN PERINATOLOGY (2002)
Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor
AM Marrache et al.
JOURNAL OF IMMUNOLOGY (2002)
[1-deamino-4-cyclohexylalanine] arginine vasopressin:: A potent and specific agonist for vasopressin V1b receptors
S Derick et al.
ENDOCRINOLOGY (2002)
Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans
M Buemi et al.
NEPHRON (2002)
Secondary structure of the third extracellular loop responsible for ligand selectivity of a mammalian gonadotropin-releasing hormone receptor
R Petry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Prostanoid receptors: ontogeny and implications in vascular physiology
DH Wright et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2001)
Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor
SA Cain et al.
BIOCHEMICAL PHARMACOLOGY (2001)
The Oxytocin Receptor System: Structure, function, and regulation
G Gimpl et al.
PHYSIOLOGICAL REVIEWS (2001)
Routing of the aquaporin-2 water channel in health and disease
PMT Deen et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2000)
Aquaretic and hormonal effects of a vasopressin V2 receptor antagonist after acute and long-term treatment in rats
C Lacour et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
JP Morello et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
